Blouin News Blogs

<img alt="" height="1" width="1" />
UPDATE 1-Data supports fast approval for Roche&#39;s breast cancer drug -FDA staff
Tue Sep 10, 2013 7:11pm IST. Sept 10 (Reuters) - Trial data on Swiss drugmaker Roche&#39;s breast cancer treatment Perjeta supported a faster approval of the drug for use in early stages of the disease, reviewers for the U.S. Food and Drug Administration said ...
FDA reviewers back Roche&#39;s Perjeta in early breast cancerFiercePharma
Roche&#39;s Perjeta Works as Early Option for Breast CancerBloomberg
FDA: Roche drug works in early-stage breast cancerBusinessweek
Bustle -WREX-TV
all 22 news articles &raquo;